Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 2
2006 2
2007 2
2008 3
2009 2
2010 4
2011 4
2012 1
2013 1
2014 6
2015 8
2016 9
2017 8
2018 6
2019 9
2020 10
2021 8
2022 2
2023 5
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: A 24-week, randomized, double-blind, active-controlled, phase 3 trial.
Xie L, Han J, Cheng Z, Liu D, Liu J, Xu C, Sun W, Li Q, Bian F, Zhang W, Chen J, Zhu Q, Thurber TK, Lock JP, Zhang B. Xie L, et al. Among authors: bian f. J Diabetes. 2024 Apr;16(4):e13526. doi: 10.1111/1753-0407.13526. J Diabetes. 2024. PMID: 38584148 Free PMC article. Clinical Trial.
Editorial: Proteostasis in central nervous system disorders.
Zhou A, Bian F. Zhou A, et al. Among authors: bian f. Front Mol Neurosci. 2024 Mar 18;17:1394171. doi: 10.3389/fnmol.2024.1394171. eCollection 2024. Front Mol Neurosci. 2024. PMID: 38562165 Free PMC article. No abstract available.
Efficacy of noiiglutide injection on body weight in obese Chinese adults without diabetes: A multicentre, randomized, double-blind, placebo-controlled, phase 2 trial.
Li Y, Cheng Z, Lu W, Li P, Jiang H, Yang J, Xu J, Zhang C, Zhang L, Wang Y, Bian F, Guo W, Yu X, Chen X, Zhao D, Feng B, Qu S, Qin J, Zhang Y, Wang L, Cheng H, Mu Y. Li Y, et al. Among authors: bian f. Diabetes Obes Metab. 2024 Mar;26(3):1057-1068. doi: 10.1111/dom.15407. Epub 2023 Dec 17. Diabetes Obes Metab. 2024. PMID: 38105342 Clinical Trial.
Diagnosis of Esophageal Squamous Cell Carcinoma by High-Performance Serum Metabolic Fingerprints: A Retrospective Study.
Huang Y, Yang H, Li J, Wang F, Liu W, Liu Y, Wang R, Duan L, Wu J, Gao Z, Cao J, Bian F, Zhang J, Zhao F, Yang S, Cao S, Yang A, Wang X, Geng M, Hao A, Li J, Cao J, Li C, Zhang Z, Zhang N, Huang Y, Zhang Y, Qian K, Zhou F. Huang Y, et al. Among authors: bian f. Small Methods. 2024 Jan;8(1):e2301046. doi: 10.1002/smtd.202301046. Epub 2023 Oct 6. Small Methods. 2024. PMID: 37803160
Efficacy and safety of janagliflozin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled on diet and exercise: A multicentre, randomized, double-blind, placebo-controlled, Phase 3 trial.
Ji L, Jiang X, Hao Q, Cheng Z, Wang K, Pang S, Liu M, Guo Y, Chen X, Su X, Ning T, Liu J, Bian F, Li Y, Zhang Z, Song W, Sun J. Ji L, et al. Among authors: bian f. Diabetes Obes Metab. 2023 May;25(5):1229-1240. doi: 10.1111/dom.14971. Epub 2023 Jan 20. Diabetes Obes Metab. 2023. PMID: 36594724 Clinical Trial.
95 results